Chief Scientific Officer Abstract Showcase
Thursday, May 30, 2024 03:45 PM - 04:45 PM
Room 202-204
Abstract Presentations
- Knock-out of the NK activating ligands in MHC-I-null human stem cell-derived β cells avoids chronic allogeneic rejection and reverts hyperglycemia in diabetic humanized mice, Raniero Chimienti, Italy
- Scalable Human iPSC-TO-3D Bioprinting Pipeline: Succesful Large-Scale production Using Automated Bioreactor Systems, Rukmini Ladi, United States
- A Functional In Vitro 3D iPSC-Derived Neuromuscular Junction Model For Use In Neurotoxin Potency Testing Or Preclinical Drug Development, Shawn Luttrell, United States
- Efficient Gene Editing in CD34+ Hematopoietic Stem and Progenitor Cells Using Non-Viral Lipid Nanoparticles, Stella Park, Canada
- Size-based Microfluidic-enriched Mesenchymal Stem Cell Subpopulation Enhanced Articular Cartilage Repair, Zheng Yang, Singapore
- Aroming Induced Pluripotent Stem cells With A Synthetic Receptor Promotes Massive Production Of Immune Effector Cells creating The Potential For "Off-The-Shelf" Immunotherapies, Ashley Yingst, United States
